Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More General business news QinetiQ extends £200m share buyback as US market challenges pressure growth QinetiQ extends its £200 million share buyback despite US sector challenges and contract delays. See how its restructuring and defence market trends impact growth. byPallavi MadhirajuMarch 22, 2025